Who is in your network?

Global Hepatitis Drugs Market Set to Exhibit Unprecedented Growth in Future

For more insights:- https://www.psmarketresearch.c....om/market-analysis/h

The increasing prevalence of different types of hepatitis types, including hepatitis B and C, is one of the major factors propelling the demand for hepatitis drugs across the world. An article published by the Hepatitis B Foundation says that hepatitis is one of the leading causes of mortality in the world. According to the World Health Organization (WHO), almost 1 million deaths are caused every year by hepatitis B and the numerous complications associated with it in the world, and nearly 500,000 deaths are caused every year across the globe, because of hepatitis C.

The other major factor powering the surge in the demand for hepatitis drugs is the soaring number of government initiatives and incentives being enacted throughout the world for promoting the development of different types of drugs for hepatitis. In addition to this, many government organizations and firms such as the WHO, the U.S. Department of Health and Human Services (HHS), American Liver Foundation, and Centers for Disease Control and Prevention (CDC) are taking various measures for encouraging diagnosis, promoting the development of drug therapies, and helping the healthcare service providers to offer tailor-made solutions to patients.

Due to the above-mentioned factors, the global hepatitis drugs market is predicted to register huge growth over the next few years. In simpler terms, hepatitis refers to the condition that arises because of the inflammation of the liver. There are drugs available for different types of hepatitis in the market namely hepatitis A, hepatitis B, and hepatitis C. Out of these three, the drugs for hepatitis C recorded huge demand in the past and this trend is expected to continue in the coming years as well, as a result of the high prevalence of this type of liver infection.

The major trends currently being witnessed in the hepatitis drugs market are the rising number of collaborations and partnerships happening amongst the leading hepatitis drugs producing companies in the world. There has been a massive rise in the number of collaborations and partnerships amongst the major hepatitis drugs producing companies over the last few years for accelerating and streamlining the various drug development processes. Additionally, most of the companies are collaborating with each other in order to develop novel solutions for the treatment of hepatitis infections.

Across the world, North America observed huge demand for hepatitis drugs in the past and this trend is also predicted to continue in the coming years. This is mainly attributed to the presence of a large geriatric population in the region. In addition to this, the governments and private organizations in many North American countries are taking numerous measures and initiatives for increasing the public awareness about hepatitis infections, their severity, and treatment and this is massively boosting the demand for hepatitis drugs in the region.

Therefore, it can be said with full confidence that owing to the rising incidence of hepatitis infections, soaring geriatric population, and the increasing awareness amongst the masses regarding hepatitis infections and their treatment options, the demand for hepatitis drugs will shoot-up across the globe in the coming years.

Why are Troubled Teens the Key Driver for European Drug of Abuse Testing Market?

For more insights:- https://www.psmarketresearch.c....om/market-analysis/e

For many people in Europe, especially emotionally disturbed teens, drugs are their best friends! But, as everyone knows, whether an addict or not, drugs are not good. Though they help people escape their troubles for a while, they lead to long-lasting ill-effects, such as risk of AIDS and hepatitis C. Due to the increasing concerns among relatives and friends about drug abuse by their loved ones, they are rapidly using methods to test the presence of such substances in the body of suspected users.

Apart from out of genuine concern, DOA testing is also done to establish doping, for legal purposes, maintain decorum at the workplace, and for medical diagnosis. The process can be accomplished with the help of several consumables, such as assay kits and reagents and rapid test kits, as well as a range of equipment, including breath analyzers, chromatography instruments, and immunoassay analyzers. Of the various consumables available, rapid test kits were the most widely adopted in the past, owing to their heavy usage in point-of-care testing centers, for mandatory screening, legal, and diagnostic purposes.

Such tests are done at laboratories, hospitals, homes, and workplaces, among which hospitals account for the largest volume. This is because as drugs lead to serious health issues and overdose is potentially fatal, users often end up in hospitals. At such places, advanced equipment and trained professionals are deployed, who undertake the testing. Moreover, in Europe, efforts are on to better the healthcare infrastructure, which include procuring modern medical devices and equipment, including those which are used for the determining the presence of DOA in the body.

The testing volume is rising in other settings too; for instance, laboratories generally offer more cost-effective services than hospitals, which is why an increasing number of people are preferring such centers for DOA testing. Moreover, the rules in workplaces regarding drug usage are becoming stricter, and many companies are implementing testing programs for their employees, to track any risky behavior. Similarly, concerned parents are using these tests at home, especially on troubled teenagers, among whom the usage of drugs is rising fast.

As per the European Monitoring Center for Drugs and Drug Abuse (EMCDDA) in 2019, 17.5 million people in the 15–34 age group were cannabis users. Similarly, 2.6 million used cocaine, 2.1 million were MDMA users, and 1.2 millions used amphetamines. People in this age group, the younger ones especially, go through all kinds of mental stress, caused due to parent and peer pressure, relationships and break-ups, bad grades, childhood trauma, and sexual abuse, which often drives them to drug addiction.

The largest DOA testing market in Europe has been the U.K., and the situation will be the same in the coming years, owing to the growing problem of drug abuse in the kingdom. According to the National Health Service (NHS), in 2018–19, 7,376 people were admitted to the hospital with drug-induced mental and behavioral disorders, which was a 30% increase from the 5,668 admissions reported in 2008–09. Moreover, rising by 16% from 2012–13, the number of hospital admissions due to drug poisoning in the kingdom stood at 18,053 in 2018–19.

Therefore, with the growing issue of DOA usage in Europe, the volume of tests is swiftly rising.

Demand for Peripheral I.V. Catheters Growing due to Surging Aged Population

For more insights:- https://www.psmarketresearch.c....om/market-analysis/p

As the prevalence of chronic diseases across the globe is increasing, the expenditure in the healthcare is also increasing. Since chronic diseases are harder to manage and often are incurable, the need for advanced solutions to deal with these problems is growing as well. Increased expenditure in the sector will facilitate the introduction of advanced healthcare solutions that can be afforded by a larger number of people. Moreover, this is will also increase the accessibility of several treatment options across the globe.

The incidence of bloodstream infections and hematoma-related complications has decreased to a certain extent owing to the introduction of these advanced catheters. The utilization of different types of peripheral I.V. catheters aids in preventing the transference of blood-borne pathogens in to other people present in the healthcare setting. There are two types of peripheral I.V. catheters, namely integrated/closed and short, between which, the demand for short peripheral I.V. catheters was higher in the past.

This being said, the demand for integrated/closed peripheral I.V. catheters is also projected to rise considerably in the coming years. Peripheral I.V. catheters are based on safety and conventional technologies, and the demand for safety variants is expected to increase significantly in the near future. These products are utilized in a number of clinical areas, namely infectious diseases, oncology, pediatric diseases, gastroenterology, and renal diseases.

The increasing geriatric population is a major reason for the growing demand for peripheral I.V. catheters across the globe. Since elderly people are more prone to chronic diseases, the burden of chronic diseases has also been surging across the global. As per the National Institutes of Health, approximately 75%–85% of the people in care facilities for the elderly are suffering from chronic pain in the U.S. Owing to the demand for peripheral I.V. catheters is rising all over the globe.

Geographically, the North American region emerged as the major peripheral I.V. catheter market in the past and is further expected to create the largest demand for these medical devices in the coming years as well. The surging geriatric population, increasing requirement for injectable drugs, and rising healthcare expenditure are leading to the growing need for peripheral I.V. catheters in the region. Within the region, the U.S. has been creating the largest demand for peripheral I.V. catheters and the situation is likely to remain the same in the coming years as well.

In conclusion, the increasing healthcare expenditure and growing geriatric population are driving the market.

How are Government Initiatives Propelling North American Defibrillators Market?

For more insights:- https://www.psmarketresearch.c....om/market-analysis/n

One in every four deaths, i.e. 647,000 deaths in the U.S., are a result of cardiovascular diseases (CVD), according to the Centers for Disease Control and Prevention (CDC). If the heart is still beating, but in an arrhythmic pattern, a defibrillator is used to treat it. The device sends an electric shock, which neutralizes a large amount of the current coming from the heart’s natural pacemaker, to allow the sinoatrial node to resume its normal functioning. Arrhythmias can be fatal if not stopped immediately, especially ventricular fibrillation (v-fib), during which the body has no pulse.

These devices come in two variants: external defibrillators and implantable cardioverter defibrillators (ICD). External ones are commonly seen at hospitals and operated by medical professionals, while ICDs are implanted inside the body, for regular cardiac care. Of these, ICDs have witnessed higher uptake, on account of the technological advancements in these instruments and rising incidence of sudden cardiac arrest (SCA). In the coming years, the external variants are predicted to witness a more rapidly increasing uptake.

A key trend in the region is itself the rising adoption of automated external defibrillators (AED). The government, at the national and state/province levels, is taking initiatives to install public-access defibrillators (PAD), which are mostly AEDs, for the use of general public, in situations of emergency. Areas which witness a high footfall, such as schools and colleges, train stations, airports, shopping centers, leisure centers, and malls, are being rapidly equipped with AEDs, so that if anyone suffers a heart issue, bystanders can use the device to restore their sinus rhythm, until medical help arrives.

For instance, the Sudden Cardiac Arrest Foundation funded several schools, under its You Can Save a Life at School AED Grant” program, to procure AEDs, in February 2016. AEDs are quite easy to use as they not only measure the voltage required to neutralize the abnormal current flowing through the heart, but also apply it themselves. On the contrary, manual defibrillators measure the voltage required, but the users have to turn the knobs on the device and apply it to the heart, through the paddles.

Presently, the U.S. is the larger contributor to the North American defibrillators market, on account of the increasing prevalence of CVDs, government initiatives aimed at making people aware about defibrillation, and presence of numerous companies offering these products. In the years to come, the adoption of defibrillators is expected to pick up quickly in Canada as well, due to almost similar reasons which lead to their high sale in the U.S.

Hence, as people realize the importance of defibrillators, and governments keep up their efforts to make them easily accessible to the public, their uptake in North America will keep rising.

Increasing Chronic Disease Cases Propelling Peripheral I.V. Catheter Use

For more insights:- https://www.psmarketresearch.c....om/market-analysis/p

Peripheral intravenous (I.V.) catheters are primarily used for blood sampling and therapeutic purposes, such as administration of blood components, fluids, antibiotics, psycholeptics, and analgesics. These catheters/cannulae are inserted into a minute peripheral vein for therapeutic purposes. The advent of these catheters has reduced the incidence of bloodstream infections and hematoma-related complications. Additionally, the usage of integrated/closed and short peripheral I.V. catheters helps in preventing the transfer of blood-borne pathogens to other patients in healthcare facilities.

In addition, the rising geriatric population will also augment the need for peripheral I.V. catheters, as this age pool is highly susceptible to chronic ailments. For instance, the National Institutes of Health, under the U.S. Department of Health and Human Services, states that in the U.S., nearly 85% of the old populace suffers from at least one chronic health condition and approximately 60% has at least two. Further, the World Population Ageing 2020 report estimates that the global population of people aged 65 years and above will reach around 1.5 billion by 2050.

Moreover, the mushrooming healthcare spending is facilitating the adoption of integrated/closed and short peripheral I.V. catheters for administering medications, fluids, and blood components in individuals suffering from chronic and acute ailments. This rise is not just being seen at hospitals, clinics, and ambulatory surgery centers (ASCs) but also in homecare settings. The leading manufacturers of these catheters include Smiths Medical Inc., Teleflex Incorporated, Argon Medical Devices Inc., Tangent Medical Technologies Inc., B. Braun Melsungen AG, Terumo Corporation, C.R. Bard Inc., and VIGMED AB.

In the coming years, these manufacturers will provide an abundant amount of peripheral I.V. catheters in the emerging economies of India, Brazil, and China due to the increasing awareness about advanced treatments in the areas of oncology, gastroenterology, renal diseases, infectious diseases, and pediatric diseases. Moreover, apart from the spurring healthcare spending, the rising focus on reducing needlestick injuries will also boost the adoption of such catheters in developing countries. Besides, the introduction of several initiatives to spread awareness about the new and improved I.V. catheters will promote their usage in the coming years.

According to P&S Intelligence, North America dominated the peripheral I.V. catheter market in the past, and it will continue to do so in the coming years. This can be credited to the spurring demand for injectable drugs, surging aging population, and escalating healthcare expenditure. In the North American region, the U.S. consumes the highest quantity of peripheral I.V. catheters. Whereas, Asia-Pacific (APAC) is expected to exhibit the fastest growth in the demand for such devices in the coming years due to similar reasons.

Thus, the rising elderly population, growing healthcare spending, and increasing cases of chronic diseases will propel the usage of peripheral I.V. catheters in healthcare settings in the coming years.